The Trump Administration’s decision to roll back emission and mileage standards for cars and trucks is bad for respiratory health.
Following reports of the Environmental Protection Agency’s move to implement broad changes that would relax environmental rules, the American Thoracic Society expressed disappointment with the plan.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Today, the American Thoracic Society and a unified group of critical care societies issued a joint statement urging the Trump administration and congress to strengthen social distancing requirements in order to curb the spread of the coronavirus, which has reached pandemic status. The statement, in its entirety, is below:
In a new study of patients with severe COVID-19 (SARS-CoV-2) hospitalized on ventilators, researchers found that lying face down was better for the lungs. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, urges governments to promote tuberculosis prevention as a critical component of TB elimination.
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
A UK study of patients participating in low-dose CT lung cancer screening highlights the importance of spirometry (breathing tests) in the assessment of possible chronic obstructive pulmonary disease (COPD), and demonstrates that over-reliance on radiological changes alone may result in detection of clinically insignificant disease. The new study is published online in the Annals of the American Thoracic Society.
“Worse than the first, and still a bad idea,” was the reaction of ATS spokesperson Mary B Rice, MD, MPH, to the EPA’s proposed rule, “Strengthening Transparency in Regulatory Science.”
The American Thoracic Society is pleased to announce the launch of the open access journal, ATS Scholar. ATS Scholar is an exciting online, peer-reviewed journal focusing on content related to education and training of health professionals relevant to adult and pediatric pulmonary, critical care and sleep medicine.
The ATS Foundation Research Program and the American Lung Association have awarded Donald Sullivan, MD, of Oregon Health & Science University a $100,000 Foundation Partner grant. The ATS Foundation Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).
Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (miniscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and may lead to chronic obstructive pulmonary disease (COPD), according to new research published online in the Annals of the American Thoracic Society.
The ATS Foundation Research Program/Pulmonary Hypertension Association has awarded Rahul Kumar, PhD, of the University of California, San Francisco, a $80,000 Foundation Partner grant. A $50,000 Foundation Partner grant was awarded to Jason Boehme, MD, also of the University of California, San Francisco. Ke Yuan, PhD, of Boston Children’s Hospital is the 2019 recipient of the Aldrighetti Research Award for Young Investigators. The award, in the amount of $80,000, is sponsored by Actelion Pharmaceuticals US, Inc, through a partnership with the Pulmonary Hypertension Association.
The ATS Foundation Research Program has announced that 17 researchers have been awarded one-year $40,000 Unrestricted Research Grants to advance pulmonary, critical care and sleep medicine.
ResMed (NYSE: RMD, ASX: RMD) and ATS Foundation have awarded their third $100,000 Research Fellowship grant to Claude Farah, PhD, of the Woolcock Institute of Medical Research in Sydney, Australia, to study how remote monitoring can help improve the management of patients with chronic obstructive pulmonary disease, or COPD.
Changes in the lung microbiome may help predict how well critically ill patients will respond to care, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
While deaths steadily declined over a decade in intensive care units at hospitals with few minority patients, in ICUs with large numbers of minority patients, there was less improvement, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right